Global COAL: Late-Phase Lung Oncology Asset Lead

GlaxoSmithKline

Rockville (MD)

On-site

USD 190,000 - 316,000

Full time

14 days+

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Benefits offered by this job

Annual bonus
Share-based long term incentive
Health care and other insurance

Job summary

GSK in the United States is seeking a Clinical Operations Asset Lead (COAL), Late Phase Lung Oncology to drive end-to-end operational delivery of complex global programs. You will translate scientific strategy into executable plans, lead Study Delivery Teams, and ensure asset success across multiple studies and indications.

The role requires deep lung oncology expertise, 10+ years in pharma R&D, and experience with BLA preparation and inspection readiness, with leadership across cross-functional

Qualifications

  • Bachelor's degree in life sciences, healthcare, business or related field.
  • Minimum of 10 years of pharmaceutical R&D or related industry experience.
  • At least 3 years of experience as COAL (or similar role) in lung cancer indications.
  • 5 years + experience successfully managed global, complex programs with multiple studies.
  • Demonstrated experience with preparing for BLA filing and BLA inspection readiness.
  • Deep therapeutic area expertise in lung oncology.

Responsibilities

  • Own the clinical operational strategy and end-to-end delivery of the asset.
  • Shape the Clinical Development Plan and Integrated Evidence Plan.
  • Lead asset-level operational planning and scenario modelling.
  • Define and oversee the asset resourcing strategy.
  • Provide strategic leadership across Study Delivery Teams.
  • Drive asset-level risk management, quality and inspection readiness.
  • Lead operational strategies across countries, patient engagement, diversity and study execution.
  • Ensure robust financial, data and stakeholder governance.

Skills

Analytical Thinking
Clinical Data Interpretation
Clinical Data Review
Clinical Development
Clinical Trial Designs
Clinical Trials Monitoring
Digital Fluency
Drug Regulatory Affairs
Executive Presence
Hematology and Oncology
Learning Agility
Matrix Leadership
Real World Evidence
Scientific Presentations

Education

Bachelor's degree in life sciences, healthcare, business or related field
Advanced degree (Master's, PhD, PharmD, MD)

Tools

Dashboards
Performance metrics

Job description

GSK in the United States is seeking a Clinical Operations Asset Lead (COAL), Late Phase Lung Oncology to drive end-to-end operational delivery of complex global programs. You will translate scientific strategy into executable plans, lead Study Delivery Teams, and ensure asset success across multiple studies and indications.

The role requires deep lung oncology expertise, 10+ years in pharma R&D, and experience with BLA preparation and inspection readiness, with leadership across cross-functional

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Senior COAL - Late-Phase Lung Oncology Lead
Senior COAL - Late-Phase Lung Oncology Lead

GlaxoSmithKline • Waltham (MA)

On-site
USD 190,000 - 316,000
Health care
Retirement benefits
Paid holidays
+2
Senior Clinical Operations Asset Lead — Lung Oncology
Senior Clinical Operations Asset Lead — Lung Oncology

GlaxoSmithKline • Philadelphia

On-site
USD 190,000 - 316,000
Health benefits
Retirement benefits
Paid holidays
+2
Clinical Operations Asset Lead, Late-Phase Lung Oncology
Clinical Operations Asset Lead, Late-Phase Lung Oncology

GlaxoSmithKline plc • Upper Providence

On-site
USD 190,000 - 316,000
Director, Global Asset Lead - Late-Phase Oncology
Director, Global Asset Lead - Late-Phase Oncology

Women In Bio • Collegeville (PA)

On-site
USD 190,000 - 316,000
Annual bonus
Long term incentive program
Health care and other insurance
+2
Director, Clinical Operations Asset Lead (COAL), Late Phase Lung Oncology
Director, Clinical Operations Asset Lead (COAL), Late Phase Lung Oncology

GlaxoSmithKline plc • Upper Providence

On-site
USD 190,000 - 316,000
Director, Clinical Operations Asset Lead (COAL), Late Phase Lung Oncology
Director, Clinical Operations Asset Lead (COAL), Late Phase Lung Oncology

GlaxoSmithKline • Upper Providence

On-site
USD 190,000 - 316,000
Health benefits
Retirement benefits
Paid holidays
+2
Director, Clinical Operations Asset Lead (COAL), Late Phase Lung Oncology
Director, Clinical Operations Asset Lead (COAL), Late Phase Lung Oncology

GlaxoSmithKline • Waltham (MA)

On-site
USD 190,000 - 316,000
Health care
Retirement benefits
Paid holidays
+2
Director, Clinical Operations Asset Lead (COAL), Late Phase Lung Oncology
Director, Clinical Operations Asset Lead (COAL), Late Phase Lung Oncology

GlaxoSmithKline • Rockville (MD)

On-site
USD 190,000 - 316,000
Annual bonus
Share-based long term incentive
Health care and other insurance
Director, Clinical Operations Asset Lead (COAL), Late Phase Lung Oncology
Director, Clinical Operations Asset Lead (COAL), Late Phase Lung Oncology

GlaxoSmithKline • Philadelphia

On-site
USD 190,000 - 316,000
Health benefits
Retirement benefits
Paid holidays
+2
Director, Clinical Operations Asset Lead (COAL), Late Phase Lung Oncology
Director, Clinical Operations Asset Lead (COAL), Late Phase Lung Oncology

GSK • Collegeville (PA)

On-site
USD 190,000 - 316,000
Annual bonus
Long term incentive program
Health care and other insurance
+2